May 2023 OKYO Pharma Limited (" OKYO " or " Company ") London Stock Exchange Delisting Further to the Dealing Announcement published by the FCA this morning, the board of directors of OKYO Pharma Limited (LSE: OKYO; NASD

Stock Exchange Delisting

to the Dealing Announcement published by the FCA this morning, the board of directors of OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO),

confirm the cancellation of its ordinary shares of no par value each ("Ordinary Shares") from listing on the standard segment

of the FCA's Official List and the cessation trading on the main market for listed securities of the LSE.

Delisting will have no impact on holders the Company's American Depositary Shares ("ADSs") (each of which represented

65 Ordinary Shares) which are traded on NASDAQ, who will receive am equal number of the new ordinary shares via DTC.

securities to which the Delisting relates are the Ordinary Shares of OKYO Pharma Limited with ISIN GG00BD3FV870. Following the Delisting,

it will no longer be possible to trade the Ordinary Shares on the Main Market or any other market of the LSE.

for holders through CREST

the share consolidation (which will take place on the Delisting Date), holders of the Company's ordinary shares in CREST will receive

a CDI (a CREST depositary interest issued by Euroclear) into their CREST account, with each CDI representing one new ordinary share.

The CDIs can be exchanged for the new ordinary shares within the CREST system. CREST holders will shortly see their holding of the

old ordinary shares replaced with a holding of CDIs with the ISIN GG00BMFG5F62. As each new ordinary share results from a 65 into 1 share

consolidation, the number of CDIs will represent the former holdings divided by a factor of 65 and rounded down to the nearest whole

for holders in certificated form

persons who currently hold Ordinary Shares in certificated form, these shareholders will receive a "DRS Statement" from the

Company's US transfer agent, by post. The DRS Statement will explain how to dematerialise the underlying shares into a trading

account. As each new ordinary share results from a 65 into 1 share consolidation, the holding on the DRS will represent the former certificated

holdings divided by a factor of 65 and rounded down to the nearest whole share.